The Core Model: Drug Discovery and Development via Effective Translational Science and Public–Private Collaboration
The Core Model: Drug Discovery and Development via Effective Translational Science and Public–Private Collaboration Ibis Sánchez-Serrano The Core Model Corporation, S.A., Panama City, Panama Drug discovery and development via collaboration…
Access Platform: A Streamlined Integrative Partnering Process at SANOFI to Commercialize University-Based Intellectual Property
Access Platform: A Streamlined Integrative Partnering Process at SANOFI to Commercialize University-Based Intellectual Property Paul R. Eynott1 and Carole Fages2 1Tech Launch Arizona, Dean’s Office, College of Science Administration, University…
The Cost of Taking Eyes Off the True End User: Focus on Patient Needs and Outcomes
The Cost of Taking Eyes Off the True End User: Focus on Patient Needs and Outcomes Deborah E. Collyar Patient Advocates in Research, Danville, CA, USA (Im)Patient Side of Drug…
Success Factors and Obstacles in Academia–Industry Partnerships: A Case Study of a Graduate Program within the Bayer–University of Cologne “Privileged Partnership”
Success Factors and Obstacles in Academia–Industry Partnerships: A Case Study of a Graduate Program within the Bayer–University of Cologne “Privileged Partnership” Stefan Herzig,1 Marion Rozowski,1 and Ingo Flamme2 1Department of…
